These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27085536)

  • 21. Alternative pre-approved and novel therapies for the treatment of anthrax.
    Head BM; Rubinstein E; Meyers AF
    BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raxibacumab.
    Mazumdar S
    MAbs; 2009; 1(6):531-8. PubMed ID: 20068396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax.
    Huang B; Xie T; Rotstein D; Fang H; Frucht DM
    Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioterrorism. Researchers question obsession with Cipro.
    Enserink M
    Science; 2001 Oct; 294(5543):759-61. PubMed ID: 11679638
    [No Abstract]   [Full Text] [Related]  

  • 25. Animal-to-Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects.
    Beliveau M; Rubets I; Bojan D; Hall C; Toth D; Kodihalli S; Kammanadiminti S
    Clin Pharmacol Ther; 2024 Feb; 115(2):248-255. PubMed ID: 38082506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside.
    Avril A; Tournier JN; Paucod JC; Fournes B; Thullier P; Pelat T
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raxibacumab for anthrax.
    Med Lett Drugs Ther; 2013 Apr; 55(1413):27-8. PubMed ID: 23545582
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques.
    Henning LN; Comer JE; Stark GV; Ray BD; Tordoff KP; Knostman KA; Meister GT
    Clin Vaccine Immunol; 2012 Nov; 19(11):1765-75. PubMed ID: 22956657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.
    Migone TS; Bolmer S; Zhong J; Corey A; Vasconcelos D; Buccellato M; Meister G
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1145-51. PubMed ID: 25487792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.
    Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D
    Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorism.
    Bennett CL; Georgantopoulos P; Gale RP; Knopf K; Hrushesky WJ; Nabhan C; Armitage JO
    Expert Opin Drug Saf; 2023; 22(9):783-788. PubMed ID: 37594915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.
    Hesse EM; Godfred-Cato S; Bower WA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protecting against future shock--inhalational anthrax.
    Nabel GJ
    N Engl J Med; 2009 Jul; 361(2):191-3. PubMed ID: 19587345
    [No Abstract]   [Full Text] [Related]  

  • 35. Does anthrax antitoxin therapy have a role in the treatment of inhalational anthrax?
    Vietri NJ
    Curr Opin Infect Dis; 2018 Jun; 31(3):257-262. PubMed ID: 29570493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
    Hilliard JJ; Jakielaszek C; Mannino F; Hossain M; Qian L; Fishman C; Demons S; Hershfield J; Soffler C; Russo R; Henning L; Novak J; O'Dwyer K
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0149723. PubMed ID: 38358266
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers.
    Subramanian GM; Cronin PW; Poley G; Weinstein A; Stoughton SM; Zhong J; Ou Y; Zmuda JF; Osborn BL; Freimuth WW
    Clin Infect Dis; 2005 Jul; 41(1):12-20. PubMed ID: 15937757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.
    Johnson SL; Chen LH; Barile E; Emdadi A; Sabet M; Yuan H; Wei J; Guiney D; Pellecchia M
    Bioorg Med Chem; 2009 May; 17(9):3352-68. PubMed ID: 19359184
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.